tiprankstipranks

Natalie Holles Insider Profile

4 Followers
Natalie Holles, SVP BD at Hyperion Therapeutics, holds 0.00 shares in Audentes Therapeutics (Ticker: ~BOLD), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds ― shares in Rubius Therapeutics (Ticker: RUBY).
tipranks
Natalie Holles

Natalie Holles
Hyperion Therapeutics (HPTX)
SVP BD

Not Ranked
Natalie Holles has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
98.11%
1.89%
0.00%
0.00%
A breakdown of Natalie Holles's holdings

Insider Roles

Third Harmonic Bio, Inc.
(THRD)
CEO, Director
Boundless Bio Inc.
(BOLD)
President & COO
Allakos
(ALLK)
Director
Day One Biopharmaceuticals
(DAWN)
Director
Roles that Natalie Holles holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Natalie Holles

Natalie Holles's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HPTX
Hyperion Therapeutics
May 08, 2015
Uninformative Sell
848.79K
~BOLD
Audentes Therapeutics
Jan 15, 2020
Uninformative Sell
6.27M
$0.00
RUBY
Rubius Therapeutics
Allakos
Director
Day One Biopharmaceuticals
Director
Third Harmonic Bio, Inc.
May 10, 2024
CEO, Director
Uninformative Buy
84.93K
$13.96M
Boundless Bio Inc.
Dec 16, 2019
President & COO
Uninformative Buy
630.77K
$268.41K
List of latest transactions for each holding click on a transaction to see Natalie Holles's performance on stock

Natalie Holles insider profile FAQ

What is the percentage of profitable transactions made by Natalie Holles?
The percentage of profitable transactions made by Natalie Holles is ―.
    What is the average return per transaction made by Natalie Holles?
    The average return per transaction made by Natalie Holles is ―.
      What stocks does Natalie Holles hold?
      Natalie Holles holds: HPTX, ~BOLD, RUBY, ALLK, DAWN, THRD, BOLD stocks.
        What was Natalie Holles’s latest transaction?
        Natalie Holles latest transaction was an Uninformative Sell of $6.27M.
          What was Natalie Holles's most profitable transaction?
          Natalie Holles’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Natalie Holles's role in Hyperion Therapeutics?
            Natalie Holles's role in Hyperion Therapeutics is SVP BD.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.